Literature DB >> 28747505

Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.

Patricia L Earl1, Jeffrey L Americo1, Bernard Moss2.   

Abstract

The castaneous (CAST) mouse, a wild-derived inbred strain, is highly susceptible to orthopoxvirus infection by intranasal and systemic routes. The 50% lethal intraperitoneal dose of vaccinia virus (VACV) was 3 PFU for CAST mice, whereas BALB/c mice survived 106 PFU. At all times and in all organs analyzed, virus titers were higher in CAST than in BALB/c mice. In individual CAST mice, luciferase-expressing VACV was seen to replicate rapidly leading to death, whereas virus levels increased for a few days and then declined in BALB/c mice. Increases in gamma interferon (IFN-γ) and tumor necrosis factor alpha (TNF-α) were delayed and low in CAST mice compared to BALB/c mice following VACV infection or poly(I-C) inoculation, consistent with differences in innate immune responses. In addition, naive CAST mice had considerably lower numbers of NK and T cells than BALB/c mice. The percentage of IFN-γ-producing CD4+ and CD8+ T cells increased following infection of CAST mice only after considerable virus spread, and the absolute cell numbers remained low. Administration of exogenous IFN-γ or -α to CAST mice before or during the first days of infection suppressed virus replication and prolonged survival, allowing the mice to make adaptive CD4+ and CD8+ T cell responses that were necessary to clear the virus after cessation of interferon treatment. Thus, insufficient innate cytokine and cellular immune responses contribute to the unique susceptibility of CAST mice to VACV, whereas the adaptive immune response can be protective only if virus replication is suppressed during the first several days of infection.IMPORTANCE Most inbred mouse strains are relatively resistant to orthopoxviruses. The castaneous (CAST) mouse is a notable exception, exhibiting extreme vulnerability to monkeypox virus, cowpox virus, and vaccinia virus and thus providing a unique model for studying pathogenicity, immunity, vaccines, and antiviral drugs. To fully utilize the CAST mouse for such purposes, it is necessary to understand the basis for virus susceptibility. We showed that naive CAST mice make low IFN-γ and TNF-α responses and have low levels of NK cells and CD4+ and CD8+ T cells compared to a resistant classical inbred mouse strain. Attenuating virus replication with one or more doses of exogenous IFN-α or -γ before or during the first few days of infection enabled the development of adaptive cellular immunity and clearance of virus. Further genetic studies may reveal the basis for the low innate immunity.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  NK cells; T cells; adaptive immunity; immune deficiency; innate immunity; interferons; poxvirus; vaccinia virus

Mesh:

Substances:

Year:  2017        PMID: 28747505      PMCID: PMC5599762          DOI: 10.1128/JVI.01042-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Characteristics of NK cell migration early after vaccinia infection.

Authors:  Martin Prlic; James Gibbs; Stephen C Jameson
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

2.  The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging.

Authors:  Fabricio Montalvao; Zacarias Garcia; Susanna Celli; Béatrice Breart; Jacques Deguine; Nico Van Rooijen; Philippe Bousso
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

3.  Genetic studies of flavivirus resistance in inbred strains derived from wild mice: evidence for a new resistance allele at the flavivirus resistance locus (Flv).

Authors:  M Y Sangster; D B Heliams; J S MacKenzie; G R Shellam
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

4.  Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models.

Authors:  Jeffrey L Americo; Bernard Moss; Patricia L Earl
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

5.  Genetic and haplotype diversity among wild-derived mouse inbred strains.

Authors:  Folami Y Ideraabdullah; Elena de la Casa-Esperón; Timothy A Bell; David A Detwiler; Terry Magnuson; Carmen Sapienza; Fernando Pardo-Manuel de Villena
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

6.  Mouse genomic variation and its effect on phenotypes and gene regulation.

Authors:  Thomas M Keane; Leo Goodstadt; Petr Danecek; Michael A White; Kim Wong; Binnaz Yalcin; Andreas Heger; Avigail Agam; Guy Slater; Martin Goodson; Nicholas A Furlotte; Eleazar Eskin; Christoffer Nellåker; Helen Whitley; James Cleak; Deborah Janowitz; Polinka Hernandez-Pliego; Andrew Edwards; T Grant Belgard; Peter L Oliver; Rebecca E McIntyre; Amarjit Bhomra; Jérôme Nicod; Xiangchao Gan; Wei Yuan; Louise van der Weyden; Charles A Steward; Sendu Bala; Jim Stalker; Richard Mott; Richard Durbin; Ian J Jackson; Anne Czechanski; José Afonso Guerra-Assunção; Leah Rae Donahue; Laura G Reinholdt; Bret A Payseur; Chris P Ponting; Ewan Birney; Jonathan Flint; David J Adams
Journal:  Nature       Date:  2011-09-14       Impact factor: 49.962

7.  A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus.

Authors:  Jennifer Stabenow; R Mark Buller; Jill Schriewer; Cheri West; John E Sagartz; Scott Parker
Journal:  J Virol       Date:  2010-02-03       Impact factor: 6.549

8.  Influenza H3N2 infection of the collaborative cross founder strains reveals highly divergent host responses and identifies a unique phenotype in CAST/EiJ mice.

Authors:  Sarah R Leist; Carolin Pilzner; Judith M A van den Brand; Leonie Dengler; Robert Geffers; Thijs Kuiken; Rudi Balling; Heike Kollmus; Klaus Schughart
Journal:  BMC Genomics       Date:  2016-02-27       Impact factor: 3.969

9.  The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy.

Authors:  Junji Uchida; Yasuhito Hamaguchi; Julie A Oliver; Jeffrey V Ravetch; Jonathan C Poe; Karen M Haas; Thomas F Tedder
Journal:  J Exp Med       Date:  2004-06-21       Impact factor: 14.307

10.  Cellular and humoral immunity against vaccinia virus infection of mice.

Authors:  Rong Xu; Aaron J Johnson; Denny Liggitt; Michael J Bevan
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  9 in total

1.  The Virulence of Different Vaccinia Virus Strains Is Directly Proportional to Their Ability To Downmodulate Specific Cell-Mediated Immune Compartments In Vivo.

Authors:  Lorena F D de Freitas; Rafael P Oliveira; Mariana C G Miranda; Raíssa P Rocha; Edel F Barbosa-Stancioli; Ana Maria C Faria; Flávio G da Fonseca
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

2.  The Perennial Use of the Green Fluorescent Protein Marker in a Live Vaccinia Virus Ankara Recombinant Platform Shows No Acute Adverse Effects in Mice.

Authors:  D S O Daian E Silva; T M G Pinho; M A Rachid; D F Barbosa-Stancioli; F G Da Fonseca
Journal:  Braz J Microbiol       Date:  2019-03-15       Impact factor: 2.476

3.  Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease.

Authors:  Eric M Mucker; Suzanne E Wollen-Roberts; Adrienne Kimmel; Josh Shamblin; Darryl Sampey; Jay W Hooper
Journal:  PLoS Negl Trop Dis       Date:  2018-06-21

Review 4.  Monkeypox re-emergence in Africa: a call to expand the concept and practice of One Health.

Authors:  Mary G Reynolds; Jeffry B Doty; Andrea M McCollum; Victoria A Olson; Yoshinori Nakazawa
Journal:  Expert Rev Anti Infect Ther       Date:  2019-01-21       Impact factor: 5.091

5.  Functionally Overlapping Variants Control Tuberculosis Susceptibility in Collaborative Cross Mice.

Authors:  Clare M Smith; Megan K Proulx; Rocky Lai; Michael C Kiritsy; Timothy A Bell; Pablo Hock; Fernando Pardo-Manuel de Villena; Martin T Ferris; Richard E Baker; Samuel M Behar; Christopher M Sassetti
Journal:  mBio       Date:  2019-11-26       Impact factor: 7.867

6.  A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma.

Authors:  Xiaoyan Dai; Wei Jiang; Liang Ma; Jie Sun; Xiaodi Yan; Jing Qian; Yan Wang; Yu Shi; Shujie Ni; Ninghua Yao
Journal:  Ann Transl Med       Date:  2021-03

7.  Interferon α/β Decoy Receptor Encoded by a Variant in the Dryvax Smallpox Vaccine Contributes to Virulence and Correlates with Severe Vaccine Side Effects.

Authors:  Ruikang Liu; Jeffrey L Americo; Patricia L Earl; Jack Villani; Catherine A Cotter; Bernard Moss
Journal:  mBio       Date:  2022-02-22       Impact factor: 7.867

Review 8.  Challenges and Achievements in Prevention and Treatment of Smallpox.

Authors:  Sharon Melamed; Tomer Israely; Nir Paran
Journal:  Vaccines (Basel)       Date:  2018-01-29

9.  Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses.

Authors:  Patricia L Earl; Jeffrey L Americo; Bernard Moss
Journal:  PLoS Pathog       Date:  2020-04-22       Impact factor: 7.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.